123 related articles for article (PubMed ID: 11877087)
21. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
22. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
[TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
24. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin: more than a lineage-specific megakaryocyte growth factor.
Kaushansky K
Stem Cells; 1997; 15 Suppl 1():97-102; discussion 102-3. PubMed ID: 9368329
[TBL] [Abstract][Full Text] [Related]
26. Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation.
Han ZC; Briere J; Abgrall JF; Le Gall G; Parent D; Sencebe L
J Biol Regul Homeost Agents; 1987; 1(4):195-200. PubMed ID: 3503520
[TBL] [Abstract][Full Text] [Related]
27. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
[TBL] [Abstract][Full Text] [Related]
28. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
29. Immature megakaryocytes in the mouse: in vitro relationship to megakaryocyte progenitor cells and mature megakaryocytes.
Long MW; Williams N; McDonald TP
J Cell Physiol; 1982 Sep; 112(3):339-44. PubMed ID: 6982272
[TBL] [Abstract][Full Text] [Related]
30. HST-1/FGF-4 stimulates proliferation of megakaryocyte progenitors synergistically and promotes megakaryocyte maturation.
Konishi H; Ochiya T; Yasuda Y; Sakamoto H; Muto T; Sugimura T; Terada M
Oncogene; 1996 Jul; 13(1):9-19. PubMed ID: 8700558
[TBL] [Abstract][Full Text] [Related]
31. A novel thrombopoietin-stem-cell factor fusion protein possesses enhanced potential in stimulating megakaryocyte proliferation and differentiation.
Zang Y; Zhang Y; Peng W; Chen B; Zhu J; Zhang C; Ouyang J; Qin J
Biotechnol Appl Biochem; 2007 Nov; 48(Pt 3):135-42. PubMed ID: 17516919
[TBL] [Abstract][Full Text] [Related]
32. The effect of partially purified thrombopoietin on guinea pig megakaryocyte ploidy in vitro.
Hill RJ; Leven RM; Levin FC; Levin J
Exp Hematol; 1989 Sep; 17(8):903-7. PubMed ID: 2767183
[TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
34. Isolation of TPO-dependent subclones from the multipotent 32D cell line.
Amabile G; Di Noia A; Alfani E; Vannucchi AM; Sanchez M; Bosco D; Migliaccio AR; Migliaccio G
Blood Cells Mol Dis; 2005; 35(2):241-52. PubMed ID: 16055357
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Stem Cells; 1997; 15(3):198-206. PubMed ID: 9170211
[TBL] [Abstract][Full Text] [Related]
36. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development.
Sigurjonsson OE; Gudmundsson KO; Haraldsdottir V; Rafnar T; Agnarsson BA; Gudmundsson S
Stem Cells Dev; 2004 Apr; 13(2):183-91. PubMed ID: 15186734
[TBL] [Abstract][Full Text] [Related]
37. [Human cytomegalovirus inhibits the proliferation of CFU-MK in vitro].
Pan S; He Z; Chen F; Wang Q; Zou X; Huang L; Yang M
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):135-7. PubMed ID: 11877064
[TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity of megakaryocyte progenitors to thrombopoietin in essential thrombocythemia.
Kawasaki H; Nakano T; Kohdera U; Kobayashi Y
Am J Hematol; 2001 Nov; 68(3):194-7. PubMed ID: 11754402
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin-induced CXC chemokines, NAP-2 and PF4, suppress polyploidization and proplatelet formation during megakaryocyte maturation.
Oda M; Kurasawa Y; Todokoro K; Nagata Y
Genes Cells; 2003 Jan; 8(1):9-15. PubMed ID: 12558795
[TBL] [Abstract][Full Text] [Related]
40. The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation.
Pan R; Wang J; Nardi MA; Li Z
Thromb Haemost; 2011 Sep; 106(3):484-90. PubMed ID: 21713325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
